Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
2.100
+0.050 (2.44%)
At close: Jul 20, 2026, 4:00 PM EDT
2.125
+0.025 (1.19%)
After-hours: Jul 20, 2026, 5:56 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $82.23 million as of July 20, 2026. Its market cap has decreased by -25.25% in one year.
Market Cap
82.23M
Enterprise Value
-2.03M
1-Year Change
-25.25%
Ranking
Category
Stock Price
$2.10
ChartMarket Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $82.23M, a decrease of -83.15%. That is a compound annual growth rate of -29.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 82.23M | -27.77% |
| Dec 31, 2025 | 113.85M | -58.58% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
| Jul 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuronetics | 112.73M |
| Rapid Micro Biosystems | 102.30M |
| Hyperfine | 92.39M |
| Nano-X Imaging | 77.95M |
| Outset Medical | 77.86M |
| LENSAR | 71.23M |
| Xtant Medical Holdings | 63.12M |
| Pulmonx | 59.13M |